Weight Loss Drugs

GLP-1 Drugs GLP-1 Medications Wegovy Semaglutide GLP-1 Agonists GLP-1 Receptor Agonists Ozempic Mounjaro Novo Nordisk Tirzepatide

3 ARTICLES

3d ago

Postpartum GLP‑1 Starts Surge in U.S., Rising More Than 20‑Fold by Early 2025

Researchers say the rapid uptake has outpaced safety evidence on breastfeeding and infant outcomes, prompting calls for focused study and stronger monitoring.

11 ARTICLES

last mo.

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

5 ARTICLES

4mo ago

Lilly’s GLP‑1 Sales and PBM Coverage Fuel Record Quarter as Pipeline Logs Durable Wins

15 ARTICLES

5mo ago

Lancet Trial Finds Semaglutide Sharply Reduces Heavy Drinking in Patients With Obesity

9 ARTICLES

6mo ago

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

8 ARTICLES

7mo ago

After Stopping GLP-1 Weight-Loss Drugs, Most Lost Weight Returns Within a Year, Analysis Finds

7 ARTICLES

7mo ago

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

9 ARTICLES

7mo ago

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

4 ARTICLES

8mo ago

Novo Nordisk’s Oral Wegovy Debuts With Strong Prescriptions as BMO Stays Cautious

3 ARTICLES

8mo ago

Three Charged in Targeted Robbery of $16,000 in GLP-1 Drugs at Bensalem Pharmacy

6 ARTICLES

8mo ago

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

6 ARTICLES

9mo ago

Eli Lilly Shifts to Access-First Strategy on GLP-1 Strength

16 ARTICLES

10mo ago

Eli Lilly Briefly Hits $1 Trillion as GLP-1 Boom Spurs Fresh Analyst Targets

8 ARTICLES

10mo ago

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

8 ARTICLES

10mo ago

Amy Tapper Defends Mounjaro Use on GMB, Confronts Trolling After 8-Stone Loss

Weight Loss Drugs

Postpartum GLP‑1 Starts Surge in U.S., Rising More Than 20‑Fold by Early 2025

GLP-1 Drugs Reshape Obesity Care

Novo Nordisk Sues Lilly Over Weight‑Loss Ads as GLP‑1 Rivalry Intensifies

Eli Lilly Trades at a High Multiple as GLP‑1 Catalysts Loom

UCL Review Finds GLP‑1 Drugs Reduce Binge Eating Symptoms

Three Men Jailed for Stealing Nearly £1m of Mounjaro

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Lilly’s GLP‑1 Sales and PBM Coverage Fuel Record Quarter as Pipeline Logs Durable Wins

Lancet Trial Finds Semaglutide Sharply Reduces Heavy Drinking in Patients With Obesity

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

Never miss stories about

Weight Loss Drugs

After Stopping GLP-1 Weight-Loss Drugs, Most Lost Weight Returns Within a Year, Analysis Finds

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

Novo Nordisk’s Oral Wegovy Debuts With Strong Prescriptions as BMO Stays Cautious

Three Charged in Targeted Robbery of $16,000 in GLP-1 Drugs at Bensalem Pharmacy

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Eli Lilly Shifts to Access-First Strategy on GLP-1 Strength

Eli Lilly Briefly Hits $1 Trillion as GLP-1 Boom Spurs Fresh Analyst Targets

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Amy Tapper Defends Mounjaro Use on GMB, Confronts Trolling After 8-Stone Loss

Never miss stories about

Weight Loss Drugs